Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CRISPR Therapeutics
Pharma
NICE rejects Vertex, CRISPR's Casgevy, asks for more data
In its draft guidance, the U.K.'s cost watchdog recognized the need for the sickle cell therapy but needs more data from Vertex on its effectiveness.
Zoey Becker
Mar 14, 2024 11:24am
'The Top Line': A closer look at new drug approvals in 2023
Jan 19, 2024 6:00am
JPM24: Bluebird CEO defends Lyfgenia pricing premium, EU retreat
Jan 10, 2024 7:10pm
JPM24, Day 3: CRISPR, BioMarin, Alkermes and more
Jan 10, 2024 7:00pm
Gene therapy gets its cultural moment on Saturday Night Live
Jan 2, 2024 8:48am
High-profile Casgevy launch could face supply hitches: doctor
Dec 21, 2023 11:46am